Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease

K Matsushita, SH Ballew, AYM Wang… - Nature Reviews …, 2022 - nature.com
Chronic kidney disease (CKD) is defined by a low glomerular filtration rate or high
albuminuria, and affects 15–20% of adults globally. CKD increases the risk of various …

Primary stroke prevention worldwide: translating evidence into action

MO Owolabi, AG Thrift, A Mahal, M Ishida… - The Lancet Public …, 2022 - thelancet.com
Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …

[HTML][HTML] Chlorthalidone vs. hydrochlorothiazide for hypertension–cardiovascular events

A Ishani, WC Cushman, SM Leatherman… - … England Journal of …, 2022 - Mass Medical Soc
Background Whether chlorthalidone is superior to hydrochlorothiazide for preventing major
adverse cardiovascular events in patients with hypertension is unclear. Methods In a …

Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease

Z Zhang, R Dalan, Z Hu, JW Wang… - Advanced …, 2022 - Wiley Online Library
Ischemic heart disease (IHD) is the leading cause of disability and mortality worldwide.
Reactive oxygen species (ROS) have been shown to play key roles in the progression of …

Sex differences in arterial hypertension: a scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association …

E Gerdts, I Sudano, S Brouwers, C Borghi… - European Heart …, 2022 - academic.oup.com
There is strong evidence that sex chromosomes and sex hormones influence blood
pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities …

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

C Razo, CA Welgan, CO Johnson, SA McLaughlin… - Nature medicine, 2022 - nature.com
High systolic blood pressure (SBP) is a major risk factor for ischemic heart disease (IHD), the
leading cause of death worldwide. Using data from published observational studies and …

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

MP Schlaich, M Bellet, MA Weber, P Danaietash… - The Lancet, 2022 - thelancet.com
Background Resistant hypertension is associated with increased cardiovascular risk. The
endothelin pathway has been implicated in the pathogenesis of hypertension, but it is …

Hypertension and COVID-19: current evidence and perspectives

G Gallo, V Calvez, C Savoia - High Blood Pressure & Cardiovascular …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a real challenge for health …

Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes

SJ Pickersgill, WT Msemburi, L Cobb, N Ide… - Nature medicine, 2022 - nature.com
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major
challenges for health systems. In this study, we analyzed the effects of better population …

2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas

NRC Campbell, MP Burnens, PK Whelton… - The Lancet Regional …, 2022 - thelancet.com
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised
blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult …